Literature DB >> 20602434

Concerted action of Helios and Ikaros controls the expression of the inositol 5-phosphatase SHIP.

Jukka Alinikula1, Pekka Kohonen, Kalle-Pekka Nera, Olli Lassila.   

Abstract

Ikaros family transcription factors have a key role in lymphoid development, and their aberrant function contributes to a multitude of lymphoid malignancies. Ikaros and Helios bind to similar DNA sequences, and Helios associates with Ikaros-containing chromatin remodeling complexes. Previously, we have shown that loss of Ikaros leads to diminished BCR-signaling strength. In this study, we describe a Helios-deficient chicken DT40 B-cell line with a BCR signaling phenotype that is the opposite to that of Ikaros-deficient cells. In contrast to Ikaros-deficient cells, Helios(-/-) B cells exhibit increased calcium release to the cytoplasm after BCR crosslinking, but diminished BCR-induced phosphorylation of signaling molecules. The inositol 5-phosphatase SHIP, an important regulator in several signaling pathways, is differentially expressed in Ikaros- and Helios-deficient cells. In the absence of Ikaros, SHIP is upregulated, whereas Helios deficiency leads to the downregulation of SHIP expression. We also show with ChIP that Ikaros binds to the promoter of the INPP5D gene-encoding SHIP. Considering the critical role of SHIP in the BCR signaling pathway, our findings provide insight into the mechanism of how both Helios and Ikaros are involved in the regulation of BCR signaling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20602434     DOI: 10.1002/eji.200940002

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  18 in total

1.  Zinc finger structure-function in Ikaros Marvin A Payne.

Authors:  Marvin A Payne
Journal:  World J Biol Chem       Date:  2011-06-26

2.  Ikaros in B cell development and function.

Authors:  Maclean Sellars; Philippe Kastner; Susan Chan
Journal:  World J Biol Chem       Date:  2011-06-26

3.  Ikaros isoforms: The saga continues.

Authors:  Zhanjun Li; Laura A Perez-Casellas; Aleksandar Savic; Chunhua Song; Sinisa Dovat
Journal:  World J Biol Chem       Date:  2011-06-26

4.  IRF4 modulates the response to BCR activation in chronic lymphocytic leukemia regulating IKAROS and SYK.

Authors:  Rossana Maffei; Stefania Fiorcari; Stefania Benatti; Claudio Giacinto Atene; Silvia Martinelli; Patrizia Zucchini; Leonardo Potenza; Mario Luppi; Roberto Marasca
Journal:  Leukemia       Date:  2021-02-23       Impact factor: 11.528

5.  Master transcription factors and mediator establish super-enhancers at key cell identity genes.

Authors:  Warren A Whyte; David A Orlando; Denes Hnisz; Brian J Abraham; Charles Y Lin; Michael H Kagey; Peter B Rahl; Tong Ihn Lee; Richard A Young
Journal:  Cell       Date:  2013-04-11       Impact factor: 41.582

6.  Possible involvement of Helios in controlling the immature B cell functions via transcriptional regulation of protein kinase Cs.

Authors:  Hidehiko Kikuchi; Masami Nakayama; Yasunari Takami; Futoshi Kuribayashi; Tatsuo Nakayama
Journal:  Results Immunol       Date:  2011-11-12

7.  Phenotypic and functional properties of Helios+ regulatory T cells.

Authors:  Daniel J Zabransky; Christopher J Nirschl; Nicholas M Durham; Ben V Park; Christina M Ceccato; Tullia C Bruno; Ada J Tam; Derese Getnet; Charles G Drake
Journal:  PLoS One       Date:  2012-03-30       Impact factor: 3.240

8.  A novel strategy for modulation of MDSC to enhance cancer immunotherapy.

Authors:  Tomar Ghansah
Journal:  Oncoimmunology       Date:  2012-09-01       Impact factor: 8.110

9.  Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function.

Authors:  Shari Pilon-Thomas; Nadine Nelson; Nasreen Vohra; Maya Jerald; Laura Pendleton; Karoly Szekeres; Tomar Ghansah
Journal:  PLoS One       Date:  2011-11-22       Impact factor: 3.240

Review 10.  Coexpression of Helios in Foxp3+ Regulatory T Cells and Its Role in Human Disease.

Authors:  Wen-Qing Yu; Ning-Fei Ji; Cheng-Jing Gu; Yan-Li Wang; Mao Huang; Ming-Shun Zhang
Journal:  Dis Markers       Date:  2021-06-22       Impact factor: 3.434

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.